Abstract
47MO The risk index of early relapse defined by MiROvaR, a miRNA-based classifier, is a potential predictive marker for bevacizumab benefit: A MITO-MANGO-ENGOT study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have